SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
FORM 6-K
REPORT OF FOREIGN PRIVATE
ISSUER
Pursuant
to Rule 13a-16 or 15d-16 of the
Securities
Exchange Act of 1934
For
the month of January 2026
Commission
file number: 001-32749
FRESENIUS MEDICAL CARE
AG
(Translation
of registrant's name into English)
Else-Kröner
Strasse 1
61346
Bad Homburg
Germany
(Address
of principal executive offices)
Indicate by check
mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F
¨
EXHIBITS
The following exhibits are being
furnished with this Report:
| Exhibit 99.1 |
Convenience translation of information disclosed on January 9, 2026 according to Article 17 Market Abuse Regulation (MAR) of the Regulation
(EU) No 596/2014. |
| |
|
| Exhibit 99.2 |
Press Release issued on January 9, 2026. |
The exhibits furnished with this report do not, individually or in the aggregate, constitute an offer to purchase or a solicitation of
any offer to sell any securities.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
DATE: January 12, 2026
| |
Fresenius Medical Care AG |
| |
|
|
| |
|
|
| |
By: |
/s/ Helen Giza |
| |
Name: |
Helen Giza |
| |
Title: |
Chief Executive Officer and Chair of the Management Board |
| |
By: |
/s/ Martin Fischer |
| |
Name: |
Martin Fischer |
| |
Title: |
Chief Financial Officer and member of the Management Board |
